Rapport Therapeutics, INC 10-K annual reports
Annual reports — audited financials, the full risk-factor list, and management’s account of the year.
NASDAQ
Rapport Therapeutics focuses on precision medicines for neurological and psychiatric disorders, advancing its lead candidate for epilepsy while addressing regulatory hurdles in other indications.